Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration
Analysis of post-marketing spontaneous ADE reports demonstrated a higher reporting rate of DM-associated with statin use compared with other medications with a significantly higher reporting rate in women compared with men. Future studies should consider mechanisms of statin-associated DM moderated by sex.
Authors
- Elizabeth Kudron
- Katarina Leyba (ORCID: https://orcid.org/0000-0002-2268-9561)
- David Kao (ORCID: https://orcid.org/0000-0002-2832-9348)
- Jane E.B. Reusch (ORCID: https://orcid.org/0000-0001-8620-1003)
- James L Martin (ORCID: https://orcid.org/0000-0003-4618-3626)
- Christina L. Aquilante (ORCID: https://orcid.org/0000-0001-6609-6920)
- Judith G. Regensteiner (ORCID: https://orcid.org/0000-0002-9331-3908)
- Elise L Shalowitz (ORCID: https://orcid.org/0000-0002-9428-036X)
Institutions
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- BMJ Open Diabetes Research & Care
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1136/bmjdrc-2024-004343
- Citations
- 7
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.01